Demand Surging for Wegovy Weight Loss Obesity Drug, Novo Nordisk Says

0
43
Nigeria police begin recruitment of constables

Danish drugmaker Novo Nordisk A/S doubled its 2025 sales target for obesity treatments to 25 billion kroner ($3.7 billion) as it boosts production of Wegovy, its newest weight-loss medication, to keep up with demand.
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here